We are live on ! Find out more
CFO

Callan Family Office Portfolio holdings

AUM $4.41B
1-Year Est. Return 26.21%
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+26.21%
3 Year Est. Return
+68.96%
5 Year Est. Return
10 Year Est. Return
AUM
$4.65B
AUM Growth
+$1.52B
Cap. Flow
+$1.42B
Cap. Flow %
30.5%
Top 10 Hldgs %
26.25%
Holding
1,130
New
282
Increased
733
Reduced
76
Closed
19

Sector Composition

Rank Sector Weight
1 Technology 22.93%
2 Financials 13.36%
3 Healthcare 9.15%
4 Industrials 7.57%
5 Consumer Discretionary 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPN icon
1001
Global Payments
GPN
$22.8B
$236K 0.01%
3,046
+334
+12% +$26.9K
SSB icon
1002
SouthState Bank Corp
SSB
$10.5B
$236K 0.01%
+2,503
New +$232K
CNM icon
1003
Core & Main
CNM
$8.71B
$234K 0.01%
+4,507
New +$231K
CPT icon
1004
Camden Property Trust
CPT
$11.3B
$234K 0.01%
+2,122
New +$221K
TXG icon
1005
10x Genomics
TXG
$6.61B
$233K 0.01%
+14,297
New +$216K
CRNX icon
1006
Crinetics Pharmaceuticals
CRNX
$8.92B
$233K 0.01%
+5,002
New +$223K
PCG icon
1007
PG&E
PCG
$38.5B
$232K 0.01%
14,461
+72
+0.5% +$1.15K
STLA icon
1008
Stellantis
STLA
$20.8B
$232K 0.01%
+21,327
New +$229K
SLGN icon
1009
Silgan Holdings
SLGN
$4.41B
$231K 0.01%
+5,728
New +$232K
FFIV icon
1010
F5
FFIV
$22.7B
$231K 0.01%
904
+175
+24% +$47.1K
WSBC icon
1011
WesBanco
WSBC
$4B
$229K ﹤0.01%
6,892
-691
-9% -$22.3K
RKLB icon
1012
Rocket Lab Corp
RKLB
$51.8B
$229K ﹤0.01%
+3,281
New +$188K
TEAM icon
1013
Atlassian
TEAM
$37.8B
$228K ﹤0.01%
+1,404
New +$220K
HQY icon
1014
HealthEquity
HQY
$8.75B
$228K ﹤0.01%
+2,484
New +$238K
RIG icon
1015
Transocean
RIG
$5.82B
$227K ﹤0.01%
+55,073
New +$214K
CDW icon
1016
CDW
CDW
$17B
$227K ﹤0.01%
1,667
+207
+14% +$30.5K
ALB icon
1017
Albemarle
ALB
$15.5B
$227K ﹤0.01%
+1,604
New +$182K
OS
1018
DELISTED
OneStream Inc
OS
$226K ﹤0.01%
+12,298
New +$234K
AEM icon
1019
Agnico Eagle Mines
AEM
$90.5B
$225K ﹤0.01%
+1,328
New +$223K
LEN.B icon
1020
Lennar Class B
LEN.B
$20.8B
$223K ﹤0.01%
2,346
+122
+5% +$13.8K
BIO icon
1021
Bio-Rad Laboratories Class A
BIO
$9.42B
$223K ﹤0.01%
+736
New +$230K
CMRE icon
1022
Costamare
CMRE
$1.77B
$223K ﹤0.01%
+14,093
New +$195K
TPL icon
1023
Texas Pacific Land
TPL
$23.5B
$222K ﹤0.01%
774
+9
+1% +$2.75K
THG icon
1024
Hanover Insurance
THG
$7.98B
$222K ﹤0.01%
+1,214
New +$218K
TSN icon
1025
Tyson Foods
TSN
$20.4B
$220K ﹤0.01%
+3,753
New +$206K

Similar funds

Callan Family Office's Q4 2025 Portfolio in Review

As of Q4 2025, Callan Family Office held 1,130 positions worth $4.65B, up 48% from $3.14B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Callan Family Office deployed $1.42B of net new capital in Q4 2025, opening 282 new positions and adding to 733 existing holdings. Its largest new stake was Vanguard Russell 3000 ETF: 228,815 shares worth $68.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Fiserv Inc, an estimated $3.75M trimmed.

  • Callan Family Office's largest Q4 2025 buy was Vanguard Russell 3000 ETF: 228,815 shares worth $68.7M.
  • Callan Family Office added most to Vanguard S&P 500 ETF in Q4 2025, an estimated $109M increase.
  • Callan Family Office's biggest Q4 2025 reduction was Fiserv Inc, cutting an estimated $3.75M.
  • Callan Family Office fully exited HubSpot in Q4 2025, selling an estimated $1.16M.
  • Callan Family Office's ten largest holdings make up 26% of its $4.65B portfolio in Q4 2025.
  • Callan Family Office opened 282 new positions and closed 19 in Q4 2025.
  • Callan Family Office's portfolio value rose 48% quarter-over-quarter to $4.65B.

Based on Callan Family Office's 13F filing for Q4 2025, filed 12 Feb 2026.